American Conference Institute’s (ACI) 12th Summit On Biosimilars

Loeb & Loeb LLP is proud to sponsor the American Conference Institute’s (ACI) 12th Summit On Biosimilars taking place from June 22-23, 2021 where partner Wanda French-Brown will be speaking on the panel "Advocating for Diversity in IP: Practical Ideas for Implementing Change" on June 22 and partner Ryan Hagglund will be speaking on the panel “New Developments Impacting Professional Responsibility in the Biologic Arena” on June 23.

About the event:
As the number of FDA-approved biosimilar products continues to grow, the need for a solid guiding framework becomes more critical than ever before. While the stakeholders wait for finality on the rules governing significant matters like interchangeability, substitution and equivalency, it is clear that biosimilars will remain a top priority for the FDA. The biosimilars market continues to maintain momentum as we head into 2021, but questions remain as to whether the U.S. market will catch up with Europe and whether biosimilars will provide their intended cost-savings.

For more information, including how to register, please visit the event website.